Ignite Creation Date:
2024-05-06 @ 4:31 PM
Last Modification Date:
2024-10-26 @ 2:11 PM
Study NCT ID:
NCT05015634
Status:
RECRUITING
Last Update Posted:
2023-03-10
First Post:
2021-08-11
Brief Title:
Telemedicine in High-Risk Cardiovascular Patients Post-ACS
Sponsor:
Imperial College London
Organization:
Imperial College London
Study Overview
Official Title:
Remote Acute Assessment of Patients With High Cardiovascular Risk Post-Acute Coronary Syndrome
Status:
RECRUITING
Status Verified Date:
2023-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
TELE-ACS
Brief Summary:
This is a non-CTIMP randomised controlled trial looking at the utilisation of telemedicine devices to provide remote clinically necessary diagnostic information without the need for hospital attendance that patients will take home with them following admission to hospital with a heart attack
Detailed Description:
Following hospital admission with a heart attack telemedicine equipment can provide patients with remote clinically necessary diagnostic information without the need for hospital attendance which they can take home when they discharge from the hospital In this project patients known to be at high risk of ACS are equipped and empowered to seek urgent medical attention without visiting the hospital if they experience symptoms and to determine whether or not to seek emergency treatment with an immediate remote specialist consultation as assessed by validated technology
Those enrolled in the intervention group will be offered telemedicine packages upon discharge from the hospital Those enrolled in the active arm will have their telemedicine package provided to the trial team when they conduct an ECG and seek medical attention In contrast in the control group routine clinical care will be provided as well as follow up by phone over 9 months
Those enrolled in the intervention group will be offered telemedicine packages upon discharge from the hospital Those enrolled in the active arm will have their telemedicine package provided to the trial team when they conduct an ECG and seek medical attention In contrast in the control group routine clinical care will be provided as well as follow up by phone over 9 months
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None